Literature DB >> 12788498

Distinct forelimb and hind limb stepping impairments in unilateral dopamine-depleted rats: use of the rotorod as a method for the qualitative analysis of skilled walking.

Ian Q Whishaw1, Katie Li, Paul A Whishaw, Bogdan Gorny, Gerlinde A Metz.   

Abstract

The rotorod test, in which animals walk on a rotating drum, is widely used to assess motor status in laboratory rodents. Performance is measured by the duration that an animal stays up on the drum as a function of drum speed. Here we report that the task provides a rich source of information about qualitative aspects of walking movements. Because movements are performed in a fixed location, they can readily be examined using high-speed video recording methods. The present study was undertaken to examine the potential of the rotorod to reveal qualitative changes in the walking movements of hemi-Parkinson analogue rats, produced by injection of 6-hydroxydopamine (6-OHDA) into the nigrostriatal bundle to deplete nigrostriatal dopamine (DA). Beginning on the day following surgery and then periodically over the next two months, the rats were filmed from frontal, lateral, and posterior views as they walked on the rotorod. Behavior was analyzed by frame-by-frame replay of the video records. Rating scales of stepping behavior indicated that the hemi-Parkinson rats were chronically impaired in their posture and in the use of the limbs contralateral to the DA-depletion. The contralateral limbs not only displayed postural and movement abnormalities, they participated less in initiating and sustaining propulsion than did the ipsilateral limbs. These findings not only reveal new deficits secondary to unilateral DA-depletion, but also show that the rotorod can provide a robust tool for the qualitative analysis of movement.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12788498     DOI: 10.1016/s0165-0270(03)00049-9

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  6 in total

Review 1.  MPTP mouse models of Parkinson's disease: an update.

Authors:  Gloria E Meredith; David J Rademacher
Journal:  J Parkinsons Dis       Date:  2011       Impact factor: 5.568

2.  D-galactose effectiveness in modeling aging and therapeutic antioxidant treatment in mice.

Authors:  Kodeeswaran Parameshwaran; Michael H Irwin; Kosta Steliou; Carl A Pinkert
Journal:  Rejuvenation Res       Date:  2011-01-04       Impact factor: 4.663

3.  Guanosine Protects Against Traumatic Brain Injury-Induced Functional Impairments and Neuronal Loss by Modulating Excitotoxicity, Mitochondrial Dysfunction, and Inflammation.

Authors:  Rogério da Rosa Gerbatin; Gustavo Cassol; Fernando Dobrachinski; Ana Paula O Ferreira; Caroline B Quines; Iuri D Della Pace; Guilherme L Busanello; Jessié M Gutierres; Cristina W Nogueira; Mauro S Oliveira; Félix A Soares; Vera M Morsch; Michele R Fighera; Luiz Fernando F Royes
Journal:  Mol Neurobiol       Date:  2016-11-09       Impact factor: 5.590

4.  Paraquat induces oxidative stress, neuronal loss in substantia nigra region and parkinsonism in adult rats: neuroprotection and amelioration of symptoms by water-soluble formulation of coenzyme Q10.

Authors:  Mallika Somayajulu-Niţu; Jagdeep K Sandhu; Jerome Cohen; Marianna Sikorska; T S Sridhar; Anca Matei; Henryk Borowy-Borowski; Siyaram Pandey
Journal:  BMC Neurosci       Date:  2009-07-27       Impact factor: 3.288

5.  Motor Learning Consolidates Arc-Expressing Neuronal Ensembles in Secondary Motor Cortex.

Authors:  Vania Yu Cao; Yizhou Ye; Surjeet Mastwal; Ming Ren; Matthew Coon; Qing Liu; Rui M Costa; Kuan Hong Wang
Journal:  Neuron       Date:  2015-06-04       Impact factor: 17.173

6.  Complete Comparison Display (CCD) evaluation of ethanol extracts of Centella asiatica and Withania somnifera shows that they can non-synergistically ameliorate biochemical and behavioural damages in MPTP induced Parkinson's model of mice.

Authors:  Maheep Bhatnagar; Ishan Goel; Tathagato Roy; Sunil Dutt Shukla; Sukant Khurana
Journal:  PLoS One       Date:  2017-05-16       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.